Post by Biogen on X
Biogen@biogen
X#News: Data from a Phase 2/3 study for SMA has been published in @NatureMedicine, exploring the potential benefit for a broad range of people living with the disease.
Read more: t.co
8 likes0 repliesPosted Feb 4, 2026